EUVIMEDEUVIMED entdecken
Crossref

Mass spectrometry analysis of young and aged mice and human Alzheimer’s disease with Lewy body pathology using on-slide tissue digestion

Joseph T Nigro, Sayantani Chatterjee, Shira Freilich, Margaret Downs, Alec Candib, Erika Berron, Thor D Stein, Joseph Zaia, Manveen K Sethi

Analytical and Bioanalytical Chemistry · 2026

DOI: 10.1007/s00216-026-06385-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Joseph T Nigro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Center for Biomedical Mass Spectrometry, Boston University Chobanian and Avedisian School of Medicine, B…. Hauptthemen laut MEDLINE: Alzheimer Disease, Tandem Mass Spectrometry, Aging, Lewy Body Disease. Die Arbeit nennt 74 Literaturangaben. Gefördert von: NIA NIH HHS, Boston University Clinical Translational Science Institute Pilot Grant Award, National Institute of Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders such as Alzheimer's disease (AD) and Lewy body disease (LBD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that predispose the brain to synaptic dysfunction and proteinopathy. Glycosylation and extracellular matrix (ECM) remodeling represent underexplored mechanisms linking aging to neurodegeneration, opening avenues for biomarker discovery, yet mass spectrometry-based glycoproteomics and glycomics studies remain limited. Here, we optimized an on-slide tissue digestion workflow for integrated glycome and proteome profiling from 5-mm brain regions from mice and humans using liquid chromatography data-independent acquisition-tandem mass spectrometry (LC-DIA-MS/MS). This workflow was applied to whole brains from age- and sex-stratified wild-type mice (n = 12) and to human postmortem prefrontal cortex tissue from individuals (n = 14) with brainstem- (n = 8) or limbic-predominant (n = 6) LBD, with or without AD co-pathology. DIA substantially increased protein, glycosylated protein, and ECM coverage by two- to threefold relative to traditional data-dependent acquisition (DDA), while library-free DIA searches further improved detection of low-abundance or region-specific proteins. In aged mouse brains, we observed increased levels of synapse-related proteins-including SYNPR, ZNT3, and HPCA-and enrichment of glutamatergic and postsynaptic pathways, reflecting age-associated synaptic remodeling. Glycomics revealed subtle shifts in the sulfation of chondroitin sulfate (CS) disaccharides with age. In human samples, AD-LBD brainstem tissue exhibited significantly reduced unsulfated, 4-O-sulfated, and total CS levels, along with differential expression of ECM, glycosylated, and mitochondrial proteins, and enrichment of mitochondrial pathways compared with LBD brainstem and AD-LBD limbic tissues. These findings indicate that AD co-pathology exerts a region-specific influence on the proteomic and glycomic landscape of LBD. Collectively, this study establishes a robust DIA-based on-slide digestion platform for high-resolution spatial glycomics and proteomics from minimal tissue, revealing aging- and pathology-specific molecular alterations relevant to neurodegeneration and providing a framework for biomarker discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTandem Mass SpectrometryAgingLewy Body DiseaseAnimalsHumansMiceFemaleAgedBrainAged, 80 and overMaleMice, Inbred C57BLGlycomicsProteomicsChromatography, LiquidProteomeLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

AgingAlzheimer’s diseaseData-independent acquisitionFormalin-fixed paraffin-embedded tissueFresh frozen tissueGlycomicsLewy body pathologyLiquid chromatographyMass spectrometryOn-slide tissue digestionProteomics

Substanzen

Proteome

Autor:innen und Institutionen

  • Department of Biochemistry and Cell Biology, Center for Biomedical Mass Spectrometry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Boston University Bioinformatics Program, Boston University, Boston, MA, USA.
  • Department of Pathology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Department of Biochemistry and Cell Biology, Center for Biomedical Mass Spectrometry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA. msethi@bu.edu.

Förderung

  • NIA NIH HHS
  • Boston University Clinical Translational Science Institute Pilot Grant Award
  • National Institute of Aging
  • BrightFocus Foundation Research Fellowship Award

Zitieren

APA

Nigro, J. T., Chatterjee, S., Freilich, S., Downs, M., Candib, A., Berron, E., Stein, T. D., Zaia, J., & Sethi, M. K. (2026). Mass spectrometry analysis of young and aged mice and human Alzheimer’s disease with Lewy body pathology using on-slide tissue digestion. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-026-06385-6

Vancouver

Nigro JT, Chatterjee S, Freilich S, Downs M, Candib A, Berron E, et al. Mass spectrometry analysis of young and aged mice and human Alzheimer’s disease with Lewy body pathology using on-slide tissue digestion. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-026-06385-6

BibTeX
@article{Nigro2026,
  author = {Nigro, Joseph T and Chatterjee, Sayantani and Freilich, Shira and Downs, Margaret and Candib, Alec and Berron, Erika and Stein, Thor D and Zaia, Joseph and Sethi, Manveen K},
  title = {Mass spectrometry analysis of young and aged mice and human Alzheimer’s disease with Lewy body pathology using on-slide tissue digestion},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  doi = {10.1007/s00216-026-06385-6}
}
Kostenlos starten →